TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 3 | 5 | 59 | 66 | 12 | -21 | 21 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 0 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/25/19 18:06 | 6/24/19 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bitterman Kevin | CA | D | P.d | 4,320 | 16.00 | 0 | 270 | 115 | 505 | I | |||||||||||||||
2/11/14 21:56 | 2/10/14 | GNCA | Genocea Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Bitterman Kevin | MA | D | P.d | 2,794 | 12.00 | 7 | 233 | 12 | 2,129 | I | 4 | 3 | 5 | 59 | 66 | 12 | -21 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |